Hims & Hers Health (HIMS) Shares Outstanding (Weighted Average) (2019 - 2026)

Hims & Hers Health has disclosed Shares Outstanding (Weighted Average) across 8 years of filings, most recently posting $228.4 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $228.4 million, up 2.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $228.4 million (up 2.87% YoY), and the FY2025 annual result was $225.0 million, up 4.18% from the prior year.
• Shares Outstanding (Weighted Average) came in at $228.4 million for Q1 2026 at Hims & Hers Health, up from $225.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $228.4 million in Q1 2026 to a low of $202.7 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $213.5 million (2024), against an average of $213.9 million.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 32.41% in 2022 and climbed 1.88% in 2023, its largest moves.
• Hims & Hers Health's Shares Outstanding (Weighted Average) stood at $204.5 million in 2022, then gained by 2.36% to $209.3 million in 2023, then climbed by 3.15% to $215.9 million in 2024, then increased by 4.18% to $225.0 million in 2025, then increased by 1.51% to $228.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $228.4 million (Q1 2026), $225.0 million (Q4 2025), and $226.3 million (Q3 2025), per Business Quant data.